Inflammation, complement activation and endothelial function in stable and unstable coronary artery disease

被引:34
作者
Kostner, KM [1 ]
Fahti, RB [1 ]
Case, C [1 ]
Hobson, P [1 ]
Tate, J [1 ]
Marwick, TH [1 ]
机构
[1] Univ Queensland, Princess Alexandra Hosp, Dept Med, Brisbane, Qld 4102, Australia
关键词
inflammation; complement; endothelial function; coronary syndromes;
D O I
10.1016/j.cca.2005.08.028
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Endothelial dysfunction plays an important role in the pathogenesis of coronary artery disease (CAD). Apart from traditional risk factors complement activation and inflammation may trigger and sustain endothelial dysfunction. We sought to assess the association between endothelial function, high sensitivity C-reactive protein (hs-CRP) and markers of complement activation in patients with either stable or unstable coronary artery disease. Methods: We prospectively recruited 78 patients, 35 patients with stable angina pectoris (SAP) and 43 patients with unstable angina pectoris (UAP). Endothelial function was assessed as brachial artery reactivity (BAR). Hs-CRP, C3a, C5a, and C1-Inhibitor (C1 inh.) were measured enzymatically. Results: Patients with IJAP showed higher median levels of hs-CRP and C3a compared to patients with SAP, while BAR was not significantly different between patient groups. In UAP patients, hs-CRP was significantly correlated with cholesterol (r = 0.27, p < 0.02), C3a (r = 0.32, p < 0.001) and C1 INH.(r = 0.41, p < 0.003), but not with flow mediated dilatation (r = 0.09, P = 0.41). Hs-CRP and C1 INH.were found to be independant predictors of IJAP in a backward stepwise logistic regression model. Conclusions: We conclude that both hs-CRP, a marker of inflammation and C3a, a marker of complement activation are elevated in patients with UAP, but not in patients with SAP. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:129 / 134
页数:6
相关论文
共 31 条
[1]   CLOSE RELATION OF ENDOTHELIAL FUNCTION IN THE HUMAN CORONARY AND PERIPHERAL CIRCULATIONS [J].
ANDERSON, TJ ;
UEHATA, A ;
GERHARD, MD ;
MEREDITH, IT ;
KNAB, S ;
DELAGRANGE, D ;
LIEBERMAN, EH ;
GANZ, P ;
CREAGER, MA ;
YEUNG, AC ;
SELWYN, AP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (05) :1235-1241
[2]   Beyond cholesterol: the enigma of atherosclerosis revisited [J].
Bhakdi, S ;
Lackner, KJ ;
Han, SR ;
Torzewski, M ;
Husmann, M .
THROMBOSIS AND HAEMOSTASIS, 2004, 91 (04) :639-645
[3]   NONINVASIVE DETECTION OF ENDOTHELIAL DYSFUNCTION IN CHILDREN AND ADULTS AT RISK OF ATHEROSCLEROSIS [J].
CELERMAJER, DS ;
SORENSEN, KE ;
GOOCH, VM ;
SPIEGELHALTER, DJ ;
MILLER, OI ;
SULLIVAN, ID ;
LLOYD, JK ;
DEANFIELD, JE .
LANCET, 1992, 340 (8828) :1111-1115
[4]   Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease [J].
Cleland, SJ ;
Sattar, N ;
Petrie, JR ;
Forouhi, NG ;
Elliott, HL ;
Connell, JMC .
CLINICAL SCIENCE, 2000, 98 (05) :531-535
[5]   The relative importance of vascular structure and function in predicting cardiovascular events [J].
Fathi, R ;
Haluska, B ;
Isbel, N ;
Short, L ;
Marwick, TH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (04) :616-623
[6]   Noninvasive tests of vascular function and structure: Why and how to perform them [J].
Fathi, R ;
Marwick, TH .
AMERICAN HEART JOURNAL, 2001, 141 (05) :694-703
[7]   Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease [J].
Fichtlscherer, S ;
Rosenberger, G ;
Walter, DH ;
Breuer, S ;
Dimmeler, S ;
Zeiher, AM .
CIRCULATION, 2000, 102 (09) :1000-1006
[8]   Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass [J].
Fitch, JCK ;
Rollins, S ;
Matis, L ;
Alford, B ;
Aranki, S ;
Collard, CD ;
Dewar, M ;
Elefteriades, J ;
Hines, R ;
Kopf, G ;
Kraker, P ;
Li, L ;
O'Hara, R ;
Rinder, C ;
Rinder, H ;
Shaw, R ;
Smith, B ;
Stahl, G ;
Shernan, SK .
CIRCULATION, 1999, 100 (25) :2499-2506
[9]   C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction [J].
Griselli, M ;
Herbert, J ;
Hutchinson, WL ;
Taylor, KM ;
Sohail, M ;
Krausz, T ;
Pepys, MB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (12) :1733-1739
[10]   Plasminogen levels and risk of coronary artery disease [J].
Hoffmeister, A ;
Rothenbacher, D ;
Khuseyinova, N ;
Brenner, H ;
Koenig, W .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (10) :1168-+